NewsRoom

(English) Europe-China Biotech Business Forum 2024

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.

(English) Chime Biologics Successfully Hosts Fuel BioGrowth Chime Day 2024 Event

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics Successfully Hosts Fuel BioGrowth Chime Day 2024 Event September 30, 2024, Wuhan – Chime Biologics, a leading global CDMO […]

(English) A Brief introduction on the Challenges and Strategies in Antibody Drug Production

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. A Brief introduction on the Challenges and Strategies in Antibody Drug Production No content available

(English) Chime Biologics won two awards at the Asia Pacific Biologics CMO Excellence Awards 2024

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics won two awards at the Asia Pacific Biologics CMO Excellence Awards 2024 Recently, at the 3rd Biologics Contract Manufacturing […]

(English) pilot-plant-of-chime-biologics

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.  pilot-plant-of-chime-biologics No content available

(English) Key Points in the Implementation of Biopharmaceutical Technology Transfer

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Key Points in the Implementation of Biopharmaceutical Technology Transfer No content available

(English) Webinar | Strategies for Characterization and Analysis of Impurities throughout the Life Cycle of Antibody Drugs

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.

(English) BIO-Europe 2024

(English) Going Global – Chime Biologics Embraces Innovation and Quality with Partners

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Going Global-Chime Biologics Embraces Innovation and Quality with Partners Foreign biopharmaceutical companies seek CDMO partners with long-term prospects, technology levels, and […]

(English) CHO Cell Line Development: Process and Key Technical Points Overview

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. CHO Cell Line Development: Process and Key Technical Points Overview No content available

categoryidArraymk-test